HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization.

Abstract
The anti-proliferative activity of mitotane (o,p'DDD) in adrenocortical cancer is mediated by its metabolites o,p'DDE and o,p'DDA. We previously demonstrated a functional link between ribonucleotide reductase M1(RRM1) expression and o,p'DDD activity, but the mechanism is unknown. In this study we assessed the impact of RRM1 on the bioavailability and cytotoxic activity of o,p'DDD, o,p'DDE and o,p'DDA in SW13 and H295R cells. In H295R cells, mitotane and its metabolites showed a similar cytotoxicity and RRM1 expression was not influenced by any drug. In SW13 cells, o,p'DDA only showed a cytotoxic activity and did not modify RRM1 expression, whereas the lack of sensitivity to o,p'DDE was associated to RRM1 gene up-modulation, as already demonstrated for o,p'DDD. RRM1 silencing in SW13 cells increased the intracellular transformation of mitotane into o,p'DDE and o,p'DDA. These data demonstrate that RRM1 gene interferes with mitotane metabolism in adrenocortical cancer cells, as a possible mechanisms of drug resistance.
AuthorsAntonina Germano, Ida Rapa, Marco Volante, Silvia De Francia, Cristina Migliore, Alfredo Berruti, Mauro Papotti, Massimo Terzolo
JournalMolecular and cellular endocrinology (Mol Cell Endocrinol) Vol. 401 Pg. 105-10 (Feb 05 2015) ISSN: 1872-8057 [Electronic] Ireland
PMID25497672 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents, Hormonal
  • Tumor Suppressor Proteins
  • Mitotane
  • RRM1 protein, human
  • Ribonucleoside Diphosphate Reductase
Topics
  • Adrenal Gland Neoplasms (genetics, metabolism)
  • Antineoplastic Agents, Hormonal (pharmacokinetics)
  • Biological Availability
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Drug Resistance, Neoplasm
  • Gene Knockdown Techniques
  • Humans
  • Mitotane (pharmacokinetics)
  • Ribonucleoside Diphosphate Reductase
  • Tumor Suppressor Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: